Keyphrases
Small Bowel Resection
76%
Epidermal Growth Factor
69%
Massive Bowel Resection
54%
Intestinal Adaptation
52%
Chemotherapy
39%
Pediatric Hematology
37%
Pediatric Cancer Patients
37%
Adaptation
28%
Intestine
27%
Enterocyte Apoptosis
26%
Bowel
26%
Stem Cell Transplantation
23%
Intestinal Resection
22%
Adaptive Process
20%
Pediatric
20%
Apoptosis
19%
Bloodstream Infection
18%
Evaluating Risks
18%
Risk Priority number
18%
Inpatient Pediatrics
18%
Pediatric Tumors
18%
Clostridium Difficile Infection
18%
Transplant Patients
18%
Germline Susceptibility
18%
Risk Factors
18%
Peritoneal Lymphomatosis
18%
Acute Promyelocytic Leukemia
18%
Duplication
18%
Intestinal Injury
18%
Failure Mode Effect Analysis
18%
CDNA Microarray Analysis
18%
Chemotherapy-induced
18%
Therapeutic Program
18%
Renal Cell Carcinoma
18%
Wilms Tumor
18%
Burkitt Lymphoma
18%
Program Design
18%
Structure Regulation
18%
Horseshoe Kidney
18%
Secondary Malignancy
18%
Failure Mode
18%
Atypical Presentation
18%
123I-MIBG
18%
Bcl-w
18%
Iodine-131 (131I)
18%
Histiocytosis
18%
Intestinal Epithelial Cells
18%
Children's Responses
18%
Cyclosporine
18%
Fetal Bovine Serum
18%
Medicine and Dentistry
Small Intestine Resection
100%
Pediatrics
50%
Epidermal Growth Factor
45%
Childhood Cancer
44%
Oncology
37%
Pediatric Hematology
37%
Programmed Cell Death
34%
Ganglioneuroblastoma
23%
Solid Malignant Neoplasm
23%
Quality Improvement
22%
Bowel Resection
22%
Diseases
22%
Infection
20%
Stem Cell Transplant
18%
Cohort Analysis
18%
Bloodstream Infection
18%
Fetal Bovine Serum
18%
Acute Promyelocytic Leukemia
18%
Lymphomatosis
18%
Burkitt's Lymphoma
18%
Cancer
18%
Combination Therapy
18%
Sodium Ion
18%
Histiocytosis
18%
Cyclosporine
18%
Epithelial Cell
18%
(3 Iodobenzyl)guanidine
18%
cDNA Microarray
18%
Clear Cell Renal Cell Carcinoma
18%
Cell Growth
18%
Iodine 131
18%
Infancy
18%
Microarray Analysis
18%
T-Cell Lymphoma
18%
Adaptive Response
16%
Parenteral Nutrition
14%
Mediator
14%
Hemophagocytic Syndrome
14%
Sham Procedure
13%
In Vitro
11%
Ileum
9%
Messenger RNA
9%
Crypt Cell
9%
Subcutaneous Nodule
9%
Liver Dysfunction
9%
Langerhans Cell Histiocytosis
9%
Experimental Therapy
9%
Cotransporter
9%
Gastrointestinal Secretion
9%
Sepsis
9%